Why attend?

Accessing and generating valuable insights from clinicogenomic and real-world data remains a massive challenge for pharmaceutical companies, often delaying discovery and development timelines. This delay impedes patient access to groundbreaking therapies and drives up R&D costs.

At Lifebit, we are committed to solving these data access and usability challenges. Our Global Federated Data Network provides rapid access to 270 million patients across all therapeutic areas and health conditions, focusing on longitudinal clinicogenomic data (over 21 million patients) and diverse ex-US datasets.

By federating data from multiple high-quality sources, we ensure clients consistently meet required patient counts, even when individual datasets fall short. This approach also unlocks otherwise inaccessible data—critical for advancing therapeutics—without the need to transfer sensitive patient data. As a result, Lifebit accelerates discoveries and development while maintaining the highest data privacy and security standards.

Join our webinar on 12 February to:

• Learn Proven Strategies: Discover practical approaches adopted by pharma leaders to overcome the obstacles of accessing and utilizing clinico-genomic and real-world data (RWD).
• Explore Our Trusted Data Lakehouse: See a live demonstration of Lifebit's Platform, which accelerates time from data access to insight by effectively linking, harmonizing, standardizing, and managing your data assets
• Enhance Your R&D for Better Results Unlock the full potential of clinico-molecular real world data to discovery and translational results, paving the way for faster, more impactful breakthroughs